| 000 | 01659 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250515221413.0 | ||
| 264 | 0 | _c20110310 | |
| 008 | 201103s 0 0 eng d | ||
| 022 | _a1861-0692 | ||
| 024 | 7 |
_a10.1007/s00392-010-0165-3 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSiller-Matula, J M | |
| 245 | 0 | 0 |
_aTacrolimus-eluting carbon-coated stents versus sirolimus-eluting stents for prevention of symptom-driven clinical end points. _h[electronic resource] |
| 260 |
_bClinical research in cardiology : official journal of the German Cardiac Society _cOct 2010 |
||
| 300 |
_a645-50 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAngioplasty, Balloon, Coronary |
| 650 | 0 | 4 | _aCarbon |
| 650 | 0 | 4 |
_aCardiovascular Diseases _xprevention & control |
| 650 | 0 | 4 |
_aCoronary Disease _xtherapy |
| 650 | 0 | 4 |
_aDrug-Eluting Stents _xadverse effects |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunosuppressive Agents _xadministration & dosage |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aRegistries |
| 650 | 0 | 4 |
_aSirolimus _xadministration & dosage |
| 650 | 0 | 4 |
_aTacrolimus _xadministration & dosage |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aTentzeris, I | |
| 700 | 1 | _aVogel, B | |
| 700 | 1 | _aSchacherl, S | |
| 700 | 1 | _aJarai, R | |
| 700 | 1 | _aGeppert, A | |
| 700 | 1 | _aUnger, G | |
| 700 | 1 | _aHuber, K | |
| 773 | 0 |
_tClinical research in cardiology : official journal of the German Cardiac Society _gvol. 99 _gno. 10 _gp. 645-50 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s00392-010-0165-3 _zAvailable from publisher's website |
| 999 |
_c19763069 _d19763069 |
||